national cancer institute

(HudsonAlpha Institute for Biotechnology) A team including researchers at the HudsonAlpha Institute and Stanford University, together with colleagues from a number of other organizations, today publishes a comprehensive analysis of genomic variation in the brain cancer glioblastoma.

These results are the first from the Cancer Genome Atlas research network, a collaborative effort funded by the National Cancer Institute and the National Human Genome Research Institute of the National Institutes of Health.

(Virginia Commonwealth University) The Virginia Commonwealth University Massey Cancer Center recently opened a National Cancer Institute-sponsored, phase II clinical study for certain sub-types of non-Hodgkin's lymphoma.

(Journal of the National Cancer Institute) The Aug. 26 online issue of the Journal of the National Cancer Institute features articles on a proposal for a new trial design that could speed drug development, a sea sponge chemical used to kill cancer cells, a new potential mouse model of leukemia development, and the association between mutations in a metabolic gene and the development of familial kidney cancer.

(University of Minnesota) The National Cancer Institute released a report today, co-edited by University of Minnesota professor Barbara Loken, that reaches the government's strongest conclusion to date that tobacco marketing and depictions of smoking in movies promote youth smoking.

(Journal of the National Cancer Institute) The August 12 online issue of the Journal of the National Cancer Institute also includes an analysis of hepatitis B genotypes associated with liver cancer; a systematic review of drugs used to treat cancer-related fatigue; evidence that doxorubicin followed by zelodronic acid reduces tumors in the absence of bone disease in mice; and a study showing that adenocarcinoma of the esophagus is increasing in both white men and white women.

(University of Texas M. D. Anderson Cancer Center) Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence, a research team led by scientists at The University of Texas M.

D. Anderson Cancer Center reported in the Aug. 12 online issue of the Journal of the National Cancer Institute.

(Journal of the National Cancer Institute) Also in the July 29 issue of the JNCI are a study that identifies patient characteristics associated with the risk of developing heart disease after anthracycline therapy, a study of lapatinib's ability to control brain metastases in a model of metastatic breast cancer, the association between mitochondrial DNA content and risk of renal cell cancer, and an experiment testing the ability of genetically modified Salmonella bacteria that express the FAS ligand to inhibit tumor growth.

(Ohio State University Medical Center) A team of researchers from Ohio State University's Comprehensive Cancer Center and the University's College of Veterinary Medicine have received a $10.9 million, five-year grant from the National Cancer Institute to further their studies of retrovirus-associated cancer.

(University of Texas at Austin) A biomedical engineering assistant professor at the University of Texas at Austin has been awarded a $1.5 million National Institutes of Health/National Cancer Institute grant to conduct nanoparticle cancer research.

(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas M. D. Anderson Cancer Center will advance two new therapeutic approaches for malignant brain tumors and develop biomarkers to guide treatment decisions under a major translational research grant from the National Cancer Institute.